Furthermore, intratumoral administration of an oncolytic virus encoding TNFα and IL-2 also enhanced anti-PD-1 efficacy in mouse melanoma by improving CD8+ T-cell infiltration [47], suggesting that delivering high concentrations of TNFα to tumors can enhance the efficacy of immunotherapy. The gene discussed is IL2; the disease is melanoma.